Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar CellBlock9 (95.41) Submitted: 7/18/2010 8:38:08 PM : Outperform Start Price: $17.76 MYL Score: -1.61

S&P 5 star

Featured Broker Partners


Advertisement